$SNPS

Synopsys shares jump on GPT-Synopsys chip design deal with OpenAI

Synopsys (SNPS) and OpenAI announced a multi-year partnership to develop GPT-Synopsys, an AI model for chip design. Synopsys shares rose 4.19% to $435.50 on the news, part of a 9.94% climb over 20 trading sessions. The deal involves revenue sharing and software licensing, but financial terms were not disclosed. Synopsys reported quarterly revenue of $2.48bn and net income of $545.8m for the quarter ended 31 July 2026.

Original reporting
Published Sep 30, 2026, 7:40 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 30, 2026, 8:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Synopsys shares jump on GPT-Synopsys chip design deal with OpenAI — source image
Decision brief

The 30-second read

$SNPSBullishHigh
01

Why it matters

The announcement triggered a 4.19% share rise on the day, with volume over three times average, suggesting strong market interest.

02

Market read

First‑report partnership creates a fresh catalyst for Synopsys, driving immediate price appreciation and potential sector‑wide AI adoption narrative.

03

What to watch

Potential regulatory scrutiny of AI models in chip design and the unknown revenue share could temper upside.

Relevance 7/10Novelty 8/10Timing: intraday today

Background

Synopsys (NASDAQ: SNPS) provides electronic design automation tools; OpenAI develops frontier AI models. The partnership aims to embed AI into chip design workflows.

Company-level read

Ticker impact

$SNPSBullishHigh confidence
Context

Synopsys announced a multi-year AI partnership with OpenAI, sending its shares up 4.19% intraday.

Expected impact

likely upward pressure as investors price in strategic AI revenue potential

Evidence & confidence

The deal is new, shares already rallied, and short interest did not drive the move, indicating fresh buying.

Market effects

May boost sentiment for the broader EDA and semiconductor design sector as AI integration gains traction.

U.S. tech stocks could see modest lift, especially AI‑focused names.

Limited to technology investors; no immediate macro impact.

Counterpoint

If the partnership terms are modest, the rally could be short‑lived and profit‑taking may dominate.

Key entities

  • Synopsys

    U.S. listed EDA software provider (NASDAQ: SNPS).

  • OpenAI

    AI research lab and commercial AI provider.

Related articles

$SNPSMed

Synopsys Details Growth Strategy and Long-term Financial Model at 2026 Investor Day

Synopsys (NASDAQ: SNPS) updated its long-term growth targets at its 2026 Investor Day, expecting fiscal year 2027 revenue of $11.15 billion (15% YoY growth). The company plans to return up to 50% of free cash flow to shareholders via share repurchases, aiming to buy back $1 billion in shares. Synopsys highlighted AI-driven demand and partnerships, including a deal with Amazon and a collaboration with OpenAI for AI-powered chip design.

$SNPSHighAI 8/10

Synopsys And OpenAI Team Up On GPT-Synopsys

Synopsys and OpenAI partnered to create GPT-Synopsys, sharing revenue based on AI-driven chip design improvements. Synopsys raised its fiscal 2027 revenue growth outlook to 15%, exceeding analyst estimates. The deal introduces value-based pricing but maintains traditional verification steps, reducing AI replacement risk.

$SNPSMed

Synopsys (SNPS) Partners with OpenAI to Integrate AI into Semico

Synopsys (SNPS) announced a multi-year partnership with OpenAI to develop GPT-Synopsys, an AI-driven model for semiconductor design. The collaboration aims to optimize workflows and includes a revenue-sharing agreement. SNPS is trading at $432, 34.4% below its GF Value™ of $658.56, with a GF Score™ of 91. Insider activity shows $48.2M in sales over the past year.

$SNPSHighAI 9/10

Synopsys stock analysis: what does today’s news tell investors?

Synopsys Inc (SNPS) stock rose 4.97% to $435.70 after announcing a $1B+ multi-year deal with Amazon.com (AMZN) for silicon IP licensing. The deal introduces a new license-plus-royalty model. Additionally, Synopsys partnered with OpenAI to develop GPT-Synopsys for semiconductor design. CEO Sassine Ghazi raised FY2027 revenue growth guidance to 15%, above analyst consensus of 11.19%.

$AMZNMedAI 9/10

Amazon Signs $1 Billion Synopsys Deal as AWS Steps Up Nvidia Challenge

Amazon (AMZN) signed a $1B+ multi-year deal with Synopsys (SNPS) to expand chip-design tech for AWS custom silicon, challenging Nvidia (NVDA). Amazon will lead Synopsys' new silicon IP business, tailoring software for Trainium AI chips and Graviton processors. Amazon's custom-chip business exceeds $25B annual revenue, growing at triple-digit rates. Synopsys may earn more with a license-plus-royalty model.